StockData
Tilray Brands, Inc. logo

Tilray Brands, Inc. (TLRY) stock

TLRYNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 11/3086% below fair value
$2.34−0.09 (-3.70%)

Close on Nov 16, 2026Market cap $345.82MP/E –Yield –

Earnings

Tilray Brands's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Jan 7, 2027
Q2 FY2027 · estimated, after the close
Revenue, Q1 FY2027
$257.10M
+22.7% on a year earlier
adjusted EPS, Q1 FY2027
-$0.02
$0.00 a year earlier
Latest guidance
Reaffirmed
Oct 8, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Tilray Brands's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q2 FY2027ended Nov 30, 2026Jan 7, 2027Expected–––––
Q1 FY2027ended Aug 31, 2026Oct 8, 2026before the open$257.10M+22.7%-$0.32-$0.02Release
Q4 FY2026ended May 31, 2026Jul 28, 2026after the close$281.70M+25.5%-$0.43$0.05Release
Q3 FY2026ended Feb 28, 2026Apr 1, 2026before the open$206.70M+11.2%-$0.24$0.02Release
Q2 FY2026ended Nov 30, 2025Jan 8, 2026after the close$217.50M+3.1%-$0.41-$0.02Release
Q1 FY2026ended Aug 31, 2025Oct 9, 2025before the open$209.50M+4.8%$0.00$0.00Release
Q4 FY2025ended May 31, 2025Jul 28, 2025after the close$224.50M-2.3%-$1.30$0.02Release
Q3 FY2025ended Feb 28, 2025Apr 8, 2025before the open$185.80M-1.3%–$0.00Release
Q2 FY2025ended Nov 30, 2024Jan 10, 2025before the open$211.00M+8.8%-$0.10$0.00Release
Q1 FY2025ended Aug 31, 2024Oct 10, 2024before the open$200.00M+13.0%-$0.04-$0.01Release
Q4 FY2024ended May 31, 2024Jul 29, 2024after the close$229.90M+24.9%-$0.04$0.04Release
Q3 FY2024ended Feb 29, 2024Apr 9, 2024before the open$188.30M+29.3%-$0.12$0.00Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Tilray Brands's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
adjusted EBITDAnon-GAAPFY2027$68.00M – $75.00M$68.00M – $75.00MReaffirmedOct 8, 2026

Guidance vs results

The last range Tilray Brands gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$850.00M – $900.00M$821.30MΣ4QBelow range

Guidance history

Every forecast Tilray Brands put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Oct 8, 2026adjusted EBITDAFY2027$68.00M – $75.00MReaffirmed
Jul 28, 2026adjusted EBITDA 5FY2027$68.00M – $75.00MNew
Apr 1, 2026adjusted EBITDAFY2026$62.00M – $72.00MReaffirmed
Jan 8, 2026Adjusted EBITDAFY2026$62.00M – $72.00MReaffirmed
Oct 9, 2025Adjusted EBITDAFY2026$62.00M – $72.00MReaffirmed
Jul 28, 2025adjusted EBITDAFY2026$62.00M – $72.00MNew
Apr 8, 2025net revenueFY2025$850.00M – $900.00MNew
Jan 10, 2025net revenuesFY2025$950.00M – $1.00BNew
Apr 9, 2024Adjusted EBITDAFY2024$60.00M – $63.00MLowered
Jan 9, 2024adjusted EBITDAFY2024$68.00M – $78.00MReaffirmed
Oct 4, 2023adjusted EBITDA targetFY2024$68.00M – $78.00MReaffirmed
Jul 26, 2023adjusted EBITDAFY2024$68.00M – $78.00MNew
Apr 10, 2023Adjusted EBITDAFY2023$60.00M – $66.00MLowered
Oct 7, 2022Adjusted EBITDAFY2023$70.00M – $80.00MReaffirmed
Jul 28, 2022Adjusted EBITDAFY2023$70.00M – $80.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Tilray Brands filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. News
  5. Results
  6. News
  7. Update
  8. Results
  9. Results
  10. News
  11. Results
  12. Results
  13. News
  14. Results
  15. Results

See a number that looks wrong?